Hydrogen sulfide, a potential novel drug, attenuates concanavalin A-induced hepatitis.
Ping Cheng,Kan Chen,Yujing Xia,Weiqi Dai,Fan Wang,Miao Shen,Chengfen Wang,Jing Yang,Rong Zhu,Huawei Zhang,Jingjing Li,Yuanyuan Zheng,Junshan Wang,Yan Zhang,Jie Lu,Yingqun Zhou,Chuanyong Guo
DOI: https://doi.org/10.2147/DDDT.S66573
IF: 4.3188
2014-01-01
Drug Design Development and Therapy
Abstract:Background: Hydrogen sulfide (H2S) is known to exert anti-inflammatory properties. Apoptosis and autophagy play important roles in concanavalin A (Con A)-induced acute hepatitis. The purpose of this study was to explore both the effect and mechanism of H2S on Con A-induced acute hepatitis. Methods: BALB/c mice were randomized into sham group, Con A-injection group, and 14 mu mol/kg of sodium hydrosulfide (NaHS, an H2S donor) pretreatment group. Results: Aspartate aminotransferase, alanine aminotransferase, and pathological damage were significantly ameliorated by NaHS pretreatment. NaHS pretreatment significantly reduced the levels of interleukin-6 and tumor necrosis factor-alpha compared with those of the Con A group. The expression of Bcl-2, Bax, Beclin-1, and LC3-2, which play important roles in the apoptosis and autophagy pathways, were also clearly affected by NaHS. Furthermore, NaHS affected the p-mTOR and p-AKT. Conclusion: H2S attenuates Con A-induced acute hepatitis by inhibiting apoptosis and autophagy, in part, through activation of the PtdIns3K-AKT1 signaling pathway.